Co-Diagnostics, Inc. CODX 深 沪
已收盘 05-15 16:00:00 美东时间
1.285
-0.345
-21.17%
华盛通- 最 高1.50
- 今 开1.45
- 成交量 41.90万股
- 最 低 1.26
- 昨 收 1.63
- 总市值 462.92万
- 52周最高 3.95
- 市盈率 静 --
- 换手率 11.63%
- 52周最低 1.26
- 委 比 39.05%
- 总股本 360.25万
- 历史最高 3.95
- 量 比 0.16
- 振 幅 14.72%
- 历史最低 1.26
- 每 手 1
- 风险率 0.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多电话会总结 ｜ Co-Diagnostics(CODX)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Co-Diagnostics业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **2026年第一季度财务表现：** - **总营收**：14.6万美元，同比增长192%（2025年同期为5万美元） - **毛利润**：亏损4.8万美元（2025年同期毛利润2.9万美元） - **净亏损**：910万美元，同比扩大21.3%（2025年同期净亏损750万美元） - **每股亏损**：4.06美元（完全稀释后），2025年同期为7.05美元 - **现金及现金等价物**：期末余额820万美元，较2025年底的1190万美元减少31.1% #
05-16 12:11
Co-Diagnostics Q1 2026 Earnings Call Transcript
Co-Diagnostics (NASDAQ:CODX) released first-quarter financial results and hoste...
05-15 05:26
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Co-Diagnostics Announces That Its JV CoMira Diagnostics Finalized A Lease Agreement For Its Planned Manufacturing Facility In Saudi Arabia
he lease execution represents a key milestone as CoMira advances domestic manufacturing capabilities within the KSA and follows the Company's previously announced approval for an industrial land allocation in Sudair
05-08 21:03
Co-Diagnostics Invited to Present at Stop TB Partnership Summit in Washington, D.C.
MTB test on Co-Dx PCR platform* to be presented at roundtable with Stop TB Partnership, U.S. Department of State, and global stakeholders SALT LAKE CITY, April 16, 2026 /PRNewswire/ -- Co-Di...
04-16 21:00
Co-Diagnostics Earnings Call: Pipeline Progress, Cash Strain
Co-Diagnostics (($CODX)) has held its Q4 earnings call. Read on for the main hi...
04-04 08:03
Co-Diagnostics JV CoMira Secures Industrial Land Allocation In Sudair Industrial City In Riyadh Region
Facility in Sudair Industrial City is expected to position CoMira among the early domestic manufacturers of molecular diagnostic testing solutions in Saudi ArabiaSALT LAKE CITY, April 2, 2026 /PRNewswire/ --
04-02 21:11
Co-Diagnostics Q4 EPS $(16.65) Down From $(10.82) YoY, Sales $263.922K Up From $149.325K YoY
Co-Diagnostics (OTC:CODX) reported quarterly losses of $(16.65) per share. This is a 53.88 percent decrease over losses of $(10.82) per share from the same period last year. The company reported $263.922 thousand in
04-01 04:07
Earnings Scheduled For March 31, 2026
Companies Reporting Before The Bell • Bitfarms (NASDAQ:BITF) is projected to re...
03-31 19:11
EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch
Co-Diagnostics ships PCR Pro and TB test kits to India, advancing clinical studies as the WHO backs NPOC diagnostics.
03-25 19:46
